Most Americans think the FDA tests supplements the way it tests drugs. It doesn’t, and not by accident. A 1994 law called DSHEA — the Dietary Supplement Health and Education Act — created a regulatory category that requires no premarket approval, no efficacy testing, and no proof of safety before a product reaches shelves. The supplement aisle at your pharmacy is closer to the produce section in regulatory terms than to the prescription counter behind it.
The premarket process is essentially a notification
To launch a new drug, a company spends an average of $1 to $2 billion and 10 years on clinical trials, then submits a New Drug Application that the FDA reviews for safety and efficacy. To launch a new supplement, a company files a “structure/function claim” notification — they tell the FDA what general benefit they intend to claim, the FDA acknowledges receipt, and the product goes on sale. The agency only acts after a problem emerges, typically after consumer complaints or hospitalizations. By then, the product has often been on the market for years and the company has often dissolved or rebranded.
Label accuracy is a documented problem
Independent testing repeatedly finds that what’s in the bottle differs from what’s on the label. A widely cited 2013 study by University of Guelph researchers used DNA barcoding on herbal supplements and found that one-third contained no detectable trace of the labeled herb, and many contained unlabeled fillers including wheat, soybean, and rice. ConsumerLab, USP, and NSF run third-party verification programs, and the share of products that fail their tests for potency, contamination, or accurate labeling has hovered around 20 to 30 percent for over a decade. Heavy metal contamination in protein powders and Ayurvedic supplements has been a recurring finding.
Adulteration is more common than the industry admits
A 2018 JAMA Network Open analysis of FDA warning letters found that supplements marketed for weight loss, sexual performance, and bodybuilding frequently contained undeclared pharmaceutical ingredients — sildenafil, sibutramine (banned in the U.S.), anabolic steroids — that the consumer was unknowingly ingesting. These aren’t fringe operators on questionable websites; some products were sold through major retailers. The FDA’s enforcement budget for this category is a fraction of what it spends on prescription drugs, and the industry produces tens of thousands of products. The agency essentially relies on harm reports to identify which to investigate.
The takeaway
The supplement industry isn’t unregulated, but the regulation that exists is post-market, complaint-driven, and chronically under-resourced. The practical consequence for consumers is that the assurance you get from a brand on a pharmacy shelf is mostly assurance from the brand itself, not from any government testing. If you take supplements, look for products with USP, NSF, or ConsumerLab verification, stick to manufacturers with a track record of recalls handled transparently, and treat any product making dramatic health claims as a red flag. The marketing infrastructure is sophisticated. The oversight infrastructure isn’t.
Leave a Reply